A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)
Clinical trial NCT01294683 · TERMINATED
Trial details
- NCT number
- NCT01294683
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-04
- Primary completion
- 2012-01-17
- Enrollment
- 977
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.